Drugs / AMI MultiStem®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00677222 | May 2008 → Mar 2010 | acute myocardial infarction | Healios K.K. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMI MultiStem | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00677222 ↗ |
| Known as | MultiStem | “MultiStem is an allogeneic bone marrow-derived adherent adult stem cell product that has shown efficacy in preclinical models of acute myocardial infarction (AMI).” PMID 22052917 ↗ Nov 2011 |
| Route | Other | “AMI MultiStem® administered via catheter into peri-vascular space of the target vessel” NCT00677222 ↗ |